Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy
Head & Neck · 2025
DOI: 10.1002/hed.28179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Ericka Francislaine Dias Costa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, São Paulo, Brazil. Hauptthemen laut MEDLINE: Cisplatin, Chemoradiotherapy, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Estadual de Campinas, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Background
This study investigated the roles of single nucleotide variants (SNVs) in genes of CDDP metabolism and their association with kidney dysfunction in patients with head and neck squamous cell carcinoma (HNSCC).
Methods
A total of 109 patients with locally advanced HNSCC, treated with CDDP, had renal function evaluated by serum creatinine level and CKD‐EPI formula, and underwent genotyping by polymerase chain reaction.
Results
Patients with GSTT1 present and ERCC1 c.354CT or TT genotypes showed 4.94% and 8.94% renal function reduction, respectively. GSTT1 present with TP53 c.215G>C (17.67%), GSTP1 c.313A>G with ERCC1 c.354C>T (17.57%), GSTP1 c.313A>G with MLH1 c.93G>A (12.49%), GSTP1 c.313A>G with MSH3 c.3133A>G (12.19%), ERCC1 c.354C>T with MLH1 c.93G>A (18.85%) and ERCC1 c.354C>T with MSH3 c.3133A>G (13.38%) combined genotypes were also associated with substantial declines in renal function.
Conclusions
Our data suggest that isolated and combined SNVs in genes enrolled in CDDP metabolism can be used to select patients for treatments that spare the kidneys from adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, São Paulo, Brazil.
- Department of Internal Medicine, School of Medical Sciences, University of Campinas, São Paulo, Brazil.
- Department of Radiology and Oncology, School of Medical Sciences, University of Campinas, São Paulo, Brazil.
ORCID-Profile: Carmen Silvia Passos Lima
Förderung
- Universidade Estadual de Campinas
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Costa, E. F. D., Ferreira, A. M. C., Mazzali, M., Lourenço, G. J., & Lima, C. S. P. (2025). Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy. Head & Neck. https://doi.org/10.1002/hed.28179
Vancouver
Costa EFD, Ferreira AMC, Mazzali M, Lourenço GJ, Lima CSP. Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy. Head & Neck. 2025. doi:10.1002/hed.28179
BibTeX
@article{Costa2025,
author = {Costa, Ericka Francislaine Dias and Ferreira, Ana Maria Castro and Mazzali, Marilda and Lourenço, Gustavo Jacob and Lima, Carmen Silvia Passos},
title = {Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28179}
}
EUVIMED